Sylvia Herter
7Patents
5h-index
19Co-inventors
52Inventor score
Filing activity: Sep 27, 2010 → Nov 21, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9266938B2 | Mutant interleukin-2 polypeptides | Chemistry; Metallurgy | 88 | Active |
| US10184009B2 | Mutant interleukin-2 polypeptides | Chemistry; Metallurgy | 33 | Active |
| US9481730B2 | DR5—FAP bispecific death receptor agonistic antibodies | Chemistry; Metallurgy | 26 | Active |
| US10323098B2 | Mutant interleukin-2 polypeptides | Chemistry; Metallurgy | 23 | Active |
| US11111312B2 | Mutant interleukin-2 polypeptides | Chemistry; Metallurgy | 6 | Active |
| US11525007B2 | Antibody fab and Fc variants | Chemistry; Metallurgy | 2 | Active |
| US10882918B2 | Bispecific T cell activating antigen binding molecules | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.